Sangamo Therapeutics (SGMO) Reports Q1 Loss, Lags Revenue Estimates

Sangamo Therapeutics (SGMO) came out with a quarterly loss of $0.27 per share versus the Zacks Consensus Estimate of a loss of$ 0.22. This compares to earnings of $0.12 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of -22.73%. A quarter ago, it was expected that this drug developer would post a loss of$ 0.25 per share when it actually produced a loss of $0.34, delivering a surprise of -36%.Over the last four quarters, the compa ...